ALANTOS PHARMACEUTICALS
Alantos Pharmaceuticals is a chemistry-driven biopharmaceutical company. It engages in the discovery and development of small molecule drugs for osteoarthritis, inflammation, and type II diabetes. Their products include Dipeptidyl and Peptidase IV inhibitor. The company offers various tissue remodeling pathways for rheumatoid arthritis, liver fibrosis, cardiovascular, chronic wound healing, and cancer. Alantos Pharmaceuticals was founded in 2002 and is based in Cambridge, Massachusetts.
ALANTOS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical Pharmaceutical
Founded:
2002-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.alantos.com
Total Employee:
10001+
Status:
Closed
Contact:
408-215-2800
Email Addresses:
[email protected]
Total Funding:
47.7 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Tag Manager Content Delivery Network Cloudflare JS CDN JS YouTube COVID-19 ASP.NET
Similar Organizations
Adartis Animal Health
Adartis Animal Health is a US registered Bio-Pharmaceutical firm focused on the licensing, registration, and marketing.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Intranasal Therapeutics
Ikano Therapeutics Inc., a specialty pharmaceutical company, focuses on developing nasal spray drug products.
Kato Pharmaceuticals
Kato Pharmaceuticals is a clinical stage Bio-pharmaceutical company dedicated to the development of novel therapies for pathologies.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Veru Inc
Veru improve lives through innovative science and medicine as a leading biopharmaceutical company focused on urology and oncology.
Current Advisors List
Investors List
Ventech
Ventech investment in Series B - Alantos Pharmaceuticals
Earlybird Venture Capital
Earlybird Venture Capital investment in Series B - Alantos Pharmaceuticals
ABN AMRO Fund
ABN AMRO Fund investment in Series B - Alantos Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Alantos Pharmaceuticals
Heidelberg Innovation
Heidelberg Innovation investment in Series B - Alantos Pharmaceuticals
SV Health Investors
SV Health Investors investment in Series B - Alantos Pharmaceuticals
Oxford Bioscience Partners
Oxford Bioscience Partners investment in Series B - Alantos Pharmaceuticals
Earlybird Venture Capital
Earlybird Venture Capital investment in Venture Round - Alantos Pharmaceuticals
